CN104490777A - 一种丁酸氯维地平脂肪乳及其制备方法 - Google Patents
一种丁酸氯维地平脂肪乳及其制备方法 Download PDFInfo
- Publication number
- CN104490777A CN104490777A CN201410819726.8A CN201410819726A CN104490777A CN 104490777 A CN104490777 A CN 104490777A CN 201410819726 A CN201410819726 A CN 201410819726A CN 104490777 A CN104490777 A CN 104490777A
- Authority
- CN
- China
- Prior art keywords
- oil
- butyrate clevidipine
- high pressure
- temperature
- injection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 35
- 239000002960 lipid emulsion Substances 0.000 title abstract description 9
- KPBZROQVTHLCDU-UHFFFAOYSA-N clevidipine Chemical compound CCCC(=O)OCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC(Cl)=C1Cl KPBZROQVTHLCDU-UHFFFAOYSA-N 0.000 title abstract description 7
- 229960003621 clevidipine butyrate Drugs 0.000 title abstract description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 36
- 210000003022 colostrum Anatomy 0.000 claims abstract description 29
- 235000021277 colostrum Nutrition 0.000 claims abstract description 29
- 238000010438 heat treatment Methods 0.000 claims abstract description 26
- 239000012071 phase Substances 0.000 claims abstract description 21
- 239000008346 aqueous phase Substances 0.000 claims abstract description 19
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 claims abstract description 13
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 claims abstract description 13
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 claims abstract description 13
- 239000005642 Oleic acid Substances 0.000 claims abstract description 13
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 claims abstract description 13
- 238000002347 injection Methods 0.000 claims abstract description 13
- 239000007924 injection Substances 0.000 claims abstract description 13
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 claims abstract description 13
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims abstract description 13
- 230000001954 sterilising effect Effects 0.000 claims abstract description 10
- 238000001816 cooling Methods 0.000 claims abstract description 5
- 229960003597 clevidipine Drugs 0.000 claims description 31
- 239000003921 oil Substances 0.000 claims description 30
- 235000019198 oils Nutrition 0.000 claims description 30
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 claims description 29
- -1 butyrate clevidipine lipid Chemical class 0.000 claims description 18
- KPBZROQVTHLCDU-GOSISDBHSA-N clevidipine Chemical compound CCCC(=O)OCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)[C@H]1C1=CC=CC(Cl)=C1Cl KPBZROQVTHLCDU-GOSISDBHSA-N 0.000 claims description 18
- FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 claims description 16
- 239000003549 soybean oil Substances 0.000 claims description 15
- 235000012424 soybean oil Nutrition 0.000 claims description 15
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 14
- 229940067606 lecithin Drugs 0.000 claims description 14
- 239000000787 lecithin Substances 0.000 claims description 14
- 235000010445 lecithin Nutrition 0.000 claims description 14
- 102000002322 Egg Proteins Human genes 0.000 claims description 13
- 108010000912 Egg Proteins Proteins 0.000 claims description 13
- 241000287828 Gallus gallus Species 0.000 claims description 13
- 210000000481 breast Anatomy 0.000 claims description 13
- 210000004681 ovum Anatomy 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- 239000012467 final product Substances 0.000 claims description 9
- 238000003756 stirring Methods 0.000 claims description 9
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims description 9
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 6
- 150000002148 esters Chemical group 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 4
- 239000004006 olive oil Substances 0.000 claims description 4
- 235000008390 olive oil Nutrition 0.000 claims description 4
- 210000000582 semen Anatomy 0.000 claims description 4
- 235000013336 milk Nutrition 0.000 claims description 3
- 239000008267 milk Substances 0.000 claims description 3
- 210000004080 milk Anatomy 0.000 claims description 3
- 239000008215 water for injection Substances 0.000 claims description 3
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 claims description 2
- WECGLUPZRHILCT-GSNKCQISSA-N 1-linoleoyl-sn-glycerol Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OC[C@@H](O)CO WECGLUPZRHILCT-GSNKCQISSA-N 0.000 claims description 2
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 claims description 2
- 239000002202 Polyethylene glycol Substances 0.000 claims description 2
- 235000019485 Safflower oil Nutrition 0.000 claims description 2
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 claims description 2
- 229940093471 ethyl oleate Drugs 0.000 claims description 2
- 235000021323 fish oil Nutrition 0.000 claims description 2
- 229940074046 glyceryl laurate Drugs 0.000 claims description 2
- 239000002609 medium Substances 0.000 claims description 2
- 229920001223 polyethylene glycol Polymers 0.000 claims description 2
- 239000003813 safflower oil Substances 0.000 claims description 2
- 235000005713 safflower oil Nutrition 0.000 claims description 2
- 239000002245 particle Substances 0.000 abstract description 2
- JQWAHKMIYCERGA-UHFFFAOYSA-N (2-nonanoyloxy-3-octadeca-9,12-dienoyloxypropoxy)-[2-(trimethylazaniumyl)ethyl]phosphinate Chemical compound CCCCCCCCC(=O)OC(COP([O-])(=O)CC[N+](C)(C)C)COC(=O)CCCCCCCC=CCC=CCCCCC JQWAHKMIYCERGA-UHFFFAOYSA-N 0.000 abstract 1
- 241000894006 Bacteria Species 0.000 abstract 1
- 235000011187 glycerol Nutrition 0.000 description 10
- 229940090044 injection Drugs 0.000 description 6
- 230000000813 microbial effect Effects 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 5
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical group CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 229940127291 Calcium channel antagonist Drugs 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000000480 calcium channel blocker Substances 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 229940036354 clevidipine injection Drugs 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 229940117389 dichlorobenzene Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410819726.8A CN104490777B (zh) | 2014-12-26 | 2014-12-26 | 一种丁酸氯维地平脂肪乳及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410819726.8A CN104490777B (zh) | 2014-12-26 | 2014-12-26 | 一种丁酸氯维地平脂肪乳及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104490777A true CN104490777A (zh) | 2015-04-08 |
CN104490777B CN104490777B (zh) | 2019-07-23 |
Family
ID=52932296
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410819726.8A Active CN104490777B (zh) | 2014-12-26 | 2014-12-26 | 一种丁酸氯维地平脂肪乳及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104490777B (zh) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1630524A (zh) * | 1999-07-28 | 2005-06-22 | 高塔姆·文诺德·达夫塔里 | 非肠道顺铂乳剂 |
CN102525918A (zh) * | 2010-12-30 | 2012-07-04 | 天津药物研究院 | 一种丁酸氯维地平的脂肪乳注射液及其制备工艺 |
-
2014
- 2014-12-26 CN CN201410819726.8A patent/CN104490777B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1630524A (zh) * | 1999-07-28 | 2005-06-22 | 高塔姆·文诺德·达夫塔里 | 非肠道顺铂乳剂 |
CN102525918A (zh) * | 2010-12-30 | 2012-07-04 | 天津药物研究院 | 一种丁酸氯维地平的脂肪乳注射液及其制备工艺 |
Non-Patent Citations (1)
Title |
---|
范允实: "《冷饮生产技术》", 31 January 2008, 中国轻工业出版社 * |
Also Published As
Publication number | Publication date |
---|---|
CN104490777B (zh) | 2019-07-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104224716B (zh) | 利用纳米乳化技术生产纳米微粒的方法 | |
WO2016169129A1 (zh) | 一种含植物油的抑菌型食用油凝胶及其制备方法 | |
CN103393631A (zh) | 一种氟比洛芬酯药物组合物 | |
WO2019080845A1 (zh) | 一种丙泊酚中/长链脂肪乳注射液的制备方法 | |
CN107308111A (zh) | 一种含橄榄油中/长链脂肪乳注射液及其制备方法 | |
JP2018515484A (ja) | カバジタキセル脂肪乳剤注射剤、その調製方法およびその使用 | |
JP2003284510A (ja) | 耐アルコール性、耐酸性、耐塩性を有する組成物および用途 | |
CN104797146A (zh) | 含乳成分饮料用乳化剂 | |
CN104490776A (zh) | 前列地尔注射液及其制备方法 | |
CN102225048A (zh) | 一种姜黄素类化合物注射溶液及其静脉注射剂 | |
CN104490778A (zh) | 一种丙泊酚脂肪乳注射液 | |
CN104490779A (zh) | 一种氟比洛芬酯脂肪乳注射液 | |
CN103520104A (zh) | 丁酸氯维地平脂肪乳注射液及其制备方法 | |
CN103520103A (zh) | 一种维生素e纳米乳及其制备方法 | |
WO2012133554A1 (ja) | プロスタグランジン含有脂肪乳剤 | |
CN105534745A (zh) | 一种乳化组合物及其在制备油水互溶型天然迷迭香抗氧化剂中的应用 | |
CN1399959A (zh) | 依托咪酯脂肪乳注射剂的制备方法 | |
CN104490777A (zh) | 一种丁酸氯维地平脂肪乳及其制备方法 | |
CN104172184A (zh) | 槲皮素纳米结构脂质载体及其制备方法 | |
KR101713219B1 (ko) | 포스파티딜콜린 및 리소포스파티딜콜린을 포함하는 주사제용 조성물 및 이의 제조방법 | |
CN103381195A (zh) | 一种脂肪乳注射剂及其制备方法 | |
CN106137788A (zh) | 一种天然植物防蚊止痒精华液及其制备方法 | |
CN106260104B (zh) | 一种复合植物油微乳液及其制备方法 | |
CN105878182A (zh) | 一种丁酸氯维地平注射用脂肪乳的制备方法 | |
CN102145238B (zh) | 一种静脉脂肪乳的检测方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240116 Address after: Room 101, 1st Floor, Building 4, No. 41 Yongda Road, Daxing District, Beijing, 100037 Patentee after: Beijing Changbai Technology Co.,Ltd. Address before: 100044 Beijing Yizhuang economic and Technological Development Zone, Chuang Chuang fourteen Street Jie Jie science park two phase 20, building 15. Patentee before: BEIJING LANDAN PHARMACEUTICAL TECHNOLOGY Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240407 Address after: 221000 No.18, Yangshan Road, Xuzhou Economic and Technological Development Zone, Xuzhou City, Jiangsu Province Patentee after: NHWA PHARMA. Corp. Country or region after: China Address before: Room 101, 1st Floor, Building 4, No. 41 Yongda Road, Daxing District, Beijing, 100037 Patentee before: Beijing Changbai Technology Co.,Ltd. Country or region before: China |